Cargando…

Treatment of scleromyxedema with IVIg

Detalles Bibliográficos
Autores principales:	Moser, David W, Griffin, Thomas A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403064/ http://dx.doi.org/10.1186/1546-0096-10-S1-A97

Ejemplares similares

Scleromyxedema: An Atypical Case
por: Thomas, Emy, et al.
Publicado: (2015)

Molecular factors modulating the anti-inflammatory activity of IVIg in ITP
por: Schwab, Inessa, et al.
Publicado: (2012)

Combination of Medical and Surgical Treatment in Scleromyxedema
por: Duran-Lemarie, Maria Caridad, et al.
Publicado: (2022)

OA14 A case of scleromyxedema with muscle involvement including myotonia and dysphagia
por: Mohareb, Marwa, et al.
Publicado: (2022)

Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
por: Saniee, Sara, et al.
Publicado: (2016)

Scleromyxedema Clinically Resembling to Scleroderma
por: Aoki, Megumi, et al.
Publicado: (2016)

Scleromyxedema, a therapeutic dilemma
por: Salas-Alanis, Julio Cesar, et al.
Publicado: (2015)

Coexistence of scleromyxedema and Sneddon syndrome
por: Furci, Antonio, et al.
Publicado: (2021)

An unusual case of granulomatous scleromyxedema
por: Michelle, Lauren, et al.
Publicado: (2022)

Dermoscopic and Cytological Findings in Scleromyxedema
por: Tehçi, Tuğba, et al.
Publicado: (2023)

Active regulatory T-cells contribute to broadened T-cell repertoire diversity in ivIg-treated SLE patients
por: Costa, Nuno, et al.
Publicado: (2011)

Atypical scleromyxedema presenting with cutaneous and cardiovascular manifestations
por: Teh, Sue-Ann, et al.
Publicado: (2016)

Scleromyxedema: a rare disorder and its treatment difficulties
por: Koronowska, Sandra Koleta, et al.
Publicado: (2013)

Peptide mimetics of anti-dsDNA idiotypes as a tool for lupus-specific IVIG preparation: specificity and efficacy in the treatment of experimental systemic lupus erythematosus
por: Blank, M, et al.
Publicado: (2005)

Plasma Cell Myeloma Masquerading as Scleromyxedema
por: Victor, Varun, et al.
Publicado: (2019)

An unusual presentation of scleromyxedema as inflammatory myopathy
por: VYSAKHA, KAVADISSERIL VIVEKANANDAN, et al.
Publicado: (2019)

Scleromyxedema: clinical diagnosis and autopsy findings
por: Sala, Ana Carolina Bulhões, et al.
Publicado: (2016)

A Rare Case of Tumoral Scleromyxedema
por: Sadeghinia, Ali, et al.
Publicado: (2020)

Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
por: Dolenc-Voljč, M., et al.
Publicado: (2013)

Scleromyxedema: A Case Report and Review of the Literature
por: Allam, Mohamed, et al.
Publicado: (2013)

A case of scleromyxedema responding to lenalidomide and dexamethasone
por: Rambhia, Sweta, et al.
Publicado: (2017)

Dermoscopy and reflectance confocal microscopy for the diagnosis of scleromyxedema
por: Mendes Bastos, Pedro, et al.
Publicado: (2019)

Paraneoplastic atypical scleromyxedema with advanced gastric cancer
por: Oh, Se Jin, et al.
Publicado: (2017)

ARNDT GOTTRON SCLEROMYXEDEMA: SUCCESSFUL RESPONSE TO TREATMENT WITH STEROID MINIPULSE AND METHOTREXATE
por: Mehta, Vandana, et al.
Publicado: (2009)

A rare association of scleromyxedema with cutis verticis gyrata
por: Koregol, Savita, et al.
Publicado: (2016)

Autologous stem cell transplantation in a patient with scleromyxedema
por: Nathan, Sunita, et al.
Publicado: (2022)

Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
por: Win, Hninyee, et al.
Publicado: (2020)

Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey
por: Ansari, Abtin, et al.
Publicado: (2022)

Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins
por: Wang, Shang-shang, et al.
Publicado: (2023)

Successful Coronary Artery Bypass Grafting in a Patient With Uncontrolled Scleromyxedema
por: Kabashneh, Sohaip, et al.
Publicado: (2020)

Eczematous reaction to IVIG for the treatment of dermatomyositis()()
por: Berk-Krauss, J., et al.
Publicado: (2018)

Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG)
por: Zhang, Wei, et al.
Publicado: (2023)

Discrete Papular Lichen Myxedematosus and Scleromyxedema with Hypothyroidism: A Report of Two Cases
por: Shenoy, Adele, et al.
Publicado: (2019)

Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report
por: Kreidy, Mazen, et al.
Publicado: (2020)

CIDP prognosis in patients with IVIG treatment‐related fluctuations
por: Cook, Melissa, et al.
Publicado: (2022)

IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010)

Early onset of scleromyxedema Arndt‐Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins
por: Kefi, Asma, et al.
Publicado: (2022)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
por: Wang, Zhouping, et al.
Publicado: (2020)

MIS-C Treatment: Is IVIG Always Necessary?
por: Licciardi, Francesco, et al.
Publicado: (2021)

Scleromyxedema (Arndt - Gottron Syndrome) Developing Under Tenofovir Treatment for Hepatitis B: Unique Presentation in a Bulgarian Patient!
por: Temelkova, Ivanka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eb95oesvjcdmi4gbde2fb7dvv2